60
Views
225
CrossRef citations to date
0
Altmetric
Original Article

The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma

, , , , , , & show all
Pages 605-610 | Received 16 Aug 1984, Accepted 15 Mar 1985, Published online: 08 Jul 2009

References

  • Rijken D C, Juhan-Vague I, De Cock F, Collen D. Measurement of human tissue-type plasmi-nogen activator by a two-site immunoradiometric assay. J Lab Clin Med 1983; 274–84
  • Verheijen J H, Rijken D C, Brommer E JP, Chang G TG. Measurement of tissue-type plasminogcn activator activity, antigen and inhibition in plasma. Clinical Aspects of Fibrinolysis and Throm-bolysis, J Jespersen, C Kluft, O Korsgaard. South Jutland University Press, EsbjergDenmark 1983; 121–31
  • Rijken D C, Juhan-Vague I, Collen D. Complexes between tissue-type plasminogen activator and proteinase inhibitors in human plasma, identified with an immunoradiometric assay. J Lab Clin Med 1983; 101: 285–94
  • Kruithof E KO, Ransijn A, Bachmann F. Inhibition of tissue plasminogen activator (TA) by human plasma. Haemostasis 1982; 11: 60, (abstract)
  • Chmielewska J, Rånby M, Wiman B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983; 13: 427–36
  • Wiman B, Chmielewska J, Ranby M. Inactivation of tissue plasminogen activator in plasma. J Biol Chem 1984; 259: 3644–7
  • Verheijen J H, Rijken D C, Chang G TC, Preston F E, Kluft C. Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol. Thromb Haemostas 1984; 51: 396–7
  • Kluft C, Verheijen J H, Chang G TG, Jie A FH, Onkelinx C. Diurnal fluctuations in the activity in blood of the fast-acting t-PA inhibitor. Haemostasis 1984; 14: 100, (abstract)
  • Brommer E JP, Verheijen J H, Chang G TG, Rijken D C. Masking of fibrinolytic response to stimulation by an inhibitor of tissue-type plasminogen activator in plasma. Thromb Haemostas 1984; 52: 154–6
  • Wijngaards G, Groeneveld E. Temporarily increased inhibition by plasma of plasminogen activator activity in severely ill patients. Haemostasis 1982; 12: 106, abstract no. 188
  • Juhan-Vague I, Rijken D C, De Cock F, Mandez C, Collen D. Extrinsic plasminogen activator levels in clinical plasma samples. Progress in Fibrinolysis, J F Davidson, F Bachmann, C A Bouvier, E KO Kruithof. Churchill Livingstone, Edinburgh 1983; vol. 6: 65–9
  • Kluft C, Verheijen J H, Cooper P, Chang G TG, Jie A FH, Blarney S L, Lowe G DO, Forbes C D, Preston F E. Postoperative changes in the activity in blood of extrinsic (tissue-type) plasminogen activator and its fast-acting inhibitor. Haemostasis 1984; 14: 26, (abstract)
  • Juhan-Vague I, Moerman B, De Cock F, Aillaud M F, Collen D. Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and uroki-nase) in normal and pathological conditions. Thromb Res 1984; 33: 523–30
  • Brakman P, Mohler E R, Astrup T. A group of patients with impaired plasma fibrinolytic system and selective inhibition of tissue activator-induced fibrnolysis. Scand J Haematol 1966; 3: 389–98
  • Chakrabarti R, Hocking E D, Fearnley G R. Reaction pattern to three stresses - electroplexy, surgery and myocardial infarction - of fibrinolysis and plasma fibrinogen. J Clin Pathol 1969; 22: 659–62
  • Maclntyre I MC, Webber R G, Crispin J R, Jones D RB, Wood J K, Allan N C, Prescott R J, Ruckley C V. Plasma fibrinolysis and postoperative deep vein thrombosis. Br J Surg 1976; 63: 694–7
  • Gordon-Smith I C, Hickman J A, Le Quesne L P. Post-operative fibrinolytic activity and deep vein thrombosis. Br J Surg 1974; 61: 231–8
  • Blix S. Studies on the fibrinolytic system in the euglobulin fraction of human plasma. Scand J Clin Lab Invest 1961; 13(suppl. 58)3–19
  • Buckell M. The effect of citrate on euglobulin methods of estimating fibrinolytic activity. J Clin Pathol 1958; 11: 403–5
  • Gram J, Jespersen J, Bach E. Levels of histidine-rich glycoprotein and plasminogen in patients with acute myocardial infarction and deep vein thrombosis. Clinical Aspects of Fibrinolysis and Thrombolysis, J Jespersen, C Kluft, O Korsgaard. South Jutland University Press, EsbjergDenmark 1983; 175–84
  • Kluft C, Brakman P, Veldhuyzen-Stolk E C. Screening of fibrinolytic activity in plasma euglobulin fractions on the fibrin plate. Progress in Chemical Fibrinolysis and Thrombolysis, J F Davidson, M M Samama, P C Desnoyers. Raven Press, New York 1976; 2: 57–65
  • Verheijen J H, Mullaart E, Chang G TG, Kluft C, Wijngaards G. A simple, sensitive spectropho-tometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemostas 1982; 48: 266–9
  • Rijken D C, Van Hinsbergh V WM, Sens E HC. Quantitation of tissue-type plasminogen activator in human endothelial cell cultures by use of an enzyme immunoassay. Thromb Res 1984; 33: 145–53
  • Verheijen J H, Chang G TG, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemostas 1984; 51: 392–5
  • Laurell C B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45–52
  • Mancini G, Carbonara A O, Heremans J F. Im-munochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965; 2: 235–40
  • Kushner I. The phenomenon of the acute phase response. Ann NY Acad Sci 1982; 389: 39–48
  • Chelladurai M, Maclntyre S S, Kishner I. Estimation of in vivo rates of C-reative protein synthesis from serum turnover studies in rabbits. Ann NY Acad Sci 1982; 389: 437–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.